CurrentCardio
Get Weekly

CurrentCardio coverage · page 4 of 13

EP Europace

Briefs 121–160 of 488 CurrentCardio has covered from this journal, newest publication first

Latest from EP Europace

All coverage, newest first

  1. Europace

    Risk of cancer following presentation with new-onset atrial fibrillation using data from UK national databases

    Diagnostic or prognostic studyArrhythmias & EP

  2. Europace

    Pre-procedural computed tomography predicts procedural complexity and complications in bidirectional rotational mechanical transvenous lead extraction

    Cohort studyArrhythmias & EP

  3. Europace

    Catheter ablation vs. anti-arrhythmic drug therapy for ventricular tachycardia in ischaemic heart disease: a meta-analysis of randomized controlled trials

    Meta-analysisArrhythmias & EP

  4. Europace

    Left ventricular ejection fraction and myocardial fibrosis in sudden cardiac death

    Cohort studyArrhythmias & EP

  5. Europace

    Women with persistent atrial fibrillation need more than pulmonary vein isolation: personalised extra-pulmonary vein ablation strategy vs. pulmonary vein isolation alone in the TAILORED-AF trial

    Secondary analysisArrhythmias & EP

  6. Europace

    Associations between cardiac resynchronization therapy and clinical outcomes according to the atrial fibrillation status in patients with heart failure with reduced ejection fraction

    Cohort studyHeart failure

  7. Europace

    Characterization of sedation strategies in real-world use of pulsed field ablation Sub-analysis of the EU-PORIA registry

    Secondary analysisArrhythmias & EP

  8. Europace

    Procedural characteristics and clinical outcomes from same-day discharge after pulsed field ablation treatment for atrial fibrillation: an admIRE trial sub-analysis

    Secondary analysisArrhythmias & EP

  9. Europace

    Antiarrhythmic drugs for cardiac arrest with a shockable rhythm and their effect on outcomes – A systematic review with meta-analysis

    Meta-analysisAcute care & resuscitation

  10. Europace

    Micra leadless pacemaker revisions: incidence, characteristics, and outcomes from a multicentre French cohort

    Cohort studyArrhythmias & EP

  11. Europace

    Association between comorbidity burden and outcomes of catheter ablation vs. medical therapy for atrial fibrillation: insights from the CABANA trial

    Secondary analysisArrhythmias & EP

  12. Europace

    Wearable smartwatches for atrial fibrillation detection and burden estimation after ablation: comparison with continuous monitoring

    Secondary analysisArrhythmias & EP

  13. Europace

    Familial risk of Wolff–Parkinson–White syndrome: a nationwide family study in Sweden

    Cohort studyArrhythmias & EP

  14. Europace

    Predictive value of ambulatory ECG monitoring for malignant arrhythmic events in genetic dilated cardiomyopathy

    Cohort studyHeart failure

  15. Europace

    Sarcopenia in atrial fibrillation: a risk factor for adverse outcomes in a UK Biobank study

    Cohort studyArrhythmias & EP

  16. Europace

    Prediction of ventricular arrhythmias and sudden cardiac death by quantification and location of late gadolinium enhancement on cardiac magnetic resonance: a systematic review and meta-analysis

    Meta-analysisArrhythmias & EP

  17. Europace

    Calmodulinopathies: the need for a registry

    Guideline or statementArrhythmias & EP

  18. Europace

    The SIDECAR 2.0 (S-ICD registry in European paediatric and young adult patients with congenital heart defects 2.0): an analysis of European S-ICD clinical practice and its evolution in paediatric patients

    Cohort studyCongenital

  19. Europace

    Comparison of readmission outcomes and complications between leadless and traditional transvenous pacemakers in older adults: a nationwide readmission analysis of 49852 admission events

    Cohort studyArrhythmias & EP

  20. Europace

    Mid- to long-term mechanical performance of left bundle branch area pacing: a comprehensive echocardiographic comparison of capture modalities

    Cohort studyArrhythmias & EP

  21. Europace

    Adverse outcomes in patients with atrial fibrillation and a pacemaker: a cohort study

    Cohort studyArrhythmias & EP

  22. Europace

    Anterior mitral isthmus line using pulsed-field ablation with the pentaspline catheter or radiofrequency ablation: procedural characteristics, safety, and mid-term outcomes

    Cohort studyArrhythmias & EP

  23. Europace

    Device-lead abnormalities and function after transcatheter tricuspid valve replacement

    Cohort studyValvular & structural

  24. Europace

    Early substrate-based catheter ablation vs. antiarrhythmic drug therapy for ventricular tachyarrhythmias among patients with prior myocardial infarction: the MANTRA-VT randomized trial

    Randomised controlled trialArrhythmias & EP

  25. Europace

    Discordance between left atrial pressure and risk scores in assessment of heart failure with preserved ejection fraction in patients with atrial fibrillation undergoing catheter ablation

    Cohort study

  26. Europace

    Prevalence and severity of atrial cardiomyopathy in patients with recently diagnosed atrial fibrillation and stroke risk factors and its association with early rhythm control: a secondary analysis of EAST-AFNET 4

    Secondary analysisArrhythmias & EP

  27. Europace

    Performance of DOAC and HAS-BLED scores in predicting major bleeding in Asian patients with non-valvular atrial fibrillation receiving direct oral anticoagulants

    Cohort studyArrhythmias & EP

  28. Europace

    Distinct patterns of ventricular fibrillation onset in primary electrical diseases: insights from a retrospective multicentre registry

    Cohort studyArrhythmias & EP

  29. Europace

    Direct oral anticoagulants in very elderly and high-bleeding-risk patients with atrial fibrillation often excluded from oral anticoagulation therapy: a nationwide population-based cohort study

    Cohort studyArrhythmias & EP

  30. Europace

    Evolution of implantable cardioverter–defibrillator shock therapy in children in the era of optimized ICD programming and remote monitoring

    Cohort studyArrhythmias & EP

  31. Europace

    Peri-procedure and Mid-Long Term Effects of Pulsed Field Ablation vs. Thermal Ablation (Cryo- or Radiofrequency) on Autonomic Nervous System Function in Atrial Fibrillation: A Systematic and Quantitative Pooled-Analysis with Potential Implications for Patient Selection (The PULSE-COLD-HEAT-ANS Collaboration)

    Meta-analysisArrhythmias & EP

  32. Europace

    Atrial fibrillation and implantable cardioverter-defibrillator in non-ischaemic heart failure with reduced ejection fraction: insights from the DANISH trial

    Secondary analysisHeart failure

  33. Europace

    Acute durability of cavotricuspid isthmus block after pulsed electric field ablation: randomized comparison of two pentaspline catheter configurations (SECTION trial)

    Randomised controlled trialArrhythmias & EP

  34. Europace

    Repeat in situ ablation vs. extensive ablation for recurrent persistent atrial fibrillation

    Randomised controlled trialArrhythmias & EP

  35. Europace

    Clinical complexity in patients with atrial fibrillation: exploring differential risk profiles from European and Asian cohorts

    Secondary analysisArrhythmias & EP

  36. Europace

    Epicardial and hybrid surgical ablation of atrial fibrillation: 1-year follow-up outcomes of the EORP EHAFA registry

    Cohort studyArrhythmias & EP

  37. Europace

    Right atrial endomysial fibrosis is associated with increased postoperative atrial fibrillation burden during 2.5 years of continuous rhythm monitoring after cardiac surgery including atrial arrhythmia surgery: RACE V Tissue Bank Study

    Cohort studyArrhythmias & EP

  38. Europace

    Haemolysis and myocardial and neural injury after monopolar pulsed field ablation using a novel lattice-tip catheter to treat atrial fibrillation

    Cohort studyArrhythmias & EP

  39. Europace

    Prevalence and multiple predictors of left atrial low voltage in paroxysmal and non-paroxysmal atrial fibrillation patients undergoing ablation: a systematic review and meta-analysis

    Meta-analysisArrhythmias & EP

  40. Europace

    Real-world experience with the pentaspline pulsed field ablation system: one-year outcomes of the FARADISE registry

    Cohort studyArrhythmias & EP

All 488 Briefs in ExploreShowing Briefs 121–160 of 488, newest first